News
-
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
Drägerwerk AG & Co. KGaA completed the share buyback for the annual employee stock program as of November 12, 2025, with a total of 70,000 preferred shares repurchased from June 3 to July 18 -
-
PRESS RELEASE
Drägerwerk AG & Co. KGaA: Dräger with strong demand, noticeable net sales growth and very good earnings performance in the first nine months of 2025
Drägerwerk AG & Co. KGaA reports strong demand, noticeable net sales growth, and very good earnings performance in the first nine months of 2025, with order intake and EBIT up -
-
PRESS RELEASE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2025: Significant increase in net sales and earnings – upper half of forecast range expected
Drägerwerk AG & Co. KGaA reports significant increase in Q3 2025 net sales and earnings, exceeding prior year's levels. Forecast for 2025 indicates strong performance in upper range -
-
-
-
PRESS RELEASE
EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2025: Earnings positive but below prior year – net sales stable – significant increase in order intake – forecast confirmed
Drägerwerk AG & Co. KGaA reports positive earnings in H1 2025 but below prior year, stable net sales, and significant increase in order intake. Forecast confirmed
